1Harrison DG, Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholester olemia and atherosclerosis: implication for impaired vasomotion. Am J Cardiol 1995;75:75B
2Anderson TJ, Merdith IT, Yeung AG, et al. The effect of cholesterollowering and antioxident nherapy on endothelium coronary vasomotion.Neng I J Med 1995;332:488
3Rutherford C,Martin W,Salame M,et al.Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combinant of antibodied to platelet- derived growth factor- BB and basic fibroblast growth factor[].Atherosclerosis.1997
4Papanicolaou DA,Wilder RL,Manolagas SC,et al.The pathophysiologic roles of interleukin-6 in human disease[].Annals of Internal Medicine.1998
5Ikeda U,Ikeda M,Seino Y,et al.Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits[].Atherosclerosis.1992
6Kranzhofer R,Clinton SK,Ishii K,et al.Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes[].Circulation Research.1996
7Ross R.The pathogenesis of atherosclerosis: a perspective for the 1990s[].Nature.1993
8Rus HG,Vlaicu R,Niculescu F.Interleukin-6 and interleukin8 protein and gene expression in human arterial atherosclerotic wall[].Atherosclerosis.1996
9Champbell J,Champbell G,Ross R.The smooth muscle in culture[].Physiological Reviews.1979
10Bourcier T,Dockter M,Hassid A.Synergistic interaction of interleukin-1 and growth factors in primary cultures of rat aortic smooth muscle cells[].Journal of Cellular Physiology.1995
